Albany, NY -- (SBWIRE) -- 10/03/2018 -- The global market for calcium pantothenate APIs is currently displaying a surge in its valuation and is anticipated to continue on the same track over the next few years. Nowadays, the prevalence of various chronic conditions that affect the brain and the central nervous system of a human is increasing significantly and, since enzyme produced by calcium pantothenate assist in maintaining the normal functioning of these organs, the demand for calcium pantothenate APIs is witnessing a remarkable rise. Researchers predict this trend to remain so over the forthcoming years.
Read Report Overview @ https://www.transparencymarketresearch.com/calcium-pantothenate-api-market.html
Apart from this, the increasing production of coenzyme A (CoA), which helps a number of metabolic pathways, is also fueling the usage for calcium pantothenate, reflecting positively on the market for calcium pantothenate APIs across the world. The efficiency of calcium pantothenate in treating nerve disorders, high cholesterol levels, fatigue, allergies, and headaches, and boosting immunity is likely to propel this market in the years to come.
Drugs and medicines, feed, and food products are the key application areas of calcium pantothenate APIs. With the increasing demand for medicines containing B5, the uptake of calcium pantothenate APIs is increasing among pharmaceutical manufacturers, resulting in a significant push to the market's growth.
Calcium pantothenate is the calcium salt of the water-soluble vitamin B5, universally found in animal and plant tissues with antioxidant properties. Pantothenate is a part of vitamin B2 complex and a component of coenzyme A. Vitamin B5 is an essential growth factor for various metabolic functions, including the metabolism of proteins, carbohydrates, and fatty acids. It is involved in the synthesis of neurotransmitters, lipids, steroid hormones, cholesterol, and hemoglobin. Calcium pantothenate is used in the treatment of hypocalcaemia, osteoporosis, postmenopausal, and vitamin B deficiency as well as in the prevention of osteoporosis.
The vitamin B5 contained within calcium pantothenate is essential for the overall functioning of the body. Calcium pantothenate also produces enzymes and helps maintain the normal functioning of the central nervous system and brain. Another important use of calcium pantothenate is its major role in the production of coenzyme A (CoA) which assists numerous metabolic pathways. Sufficient amounts of calcium pantothenate are potentially beneficial for nerve disorders, fatigue, high cholesterol, headaches, allergies, and to boost immunity. It is often used as a dietary supplement because as a salt, it can become more stable in the digestive tract, allowing better absorption.
The calcium pantothenate API market has been segmented based on product type into the following segments: 99.5% calcium pantothenate API, 99.7% calcium pantothenate API, and 99.8% calcium pantothenate API. These types are differentiated on the basis of purity grades. Similarly, in terms of application, the global market can be divided into medicine, feed, and food categories, depending on the usage of calcium pantothenate for various purposes. Pantethine is the disulphide form of pantothenic acid, which is also used in dietary supplements. It is an active form of vitamin B5 as it comprises the sulfhydryl-group required for biological activity in coenzyme A.
With the rising number of pharmaceutical manufacturers and requirement for medicines containing vitamin B5, demand for calcium pantothenate API is also on the rise. The strong growth of the API industry in North America and Asia Pacific, especially in China, is anticipated to drive the global calcium pantothenate API market. The global demand for minerals and nutraceuticals is also likely to propel the global calcium pantothenate API market in the future.
Geographically, the global calcium pantothenate API market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America constituted the maximum share in the global calcium pantothenate API market, followed by Europe and Asia. Recently, Asia has been found to surpass North America in the production and supply of APIs for the global pharmaceutical industry. Asia Pacific is predicted to report a higher growth rate in the next few years mainly because of the increasing production capacity of its API industry. Similarly, in Latin America, especially Brazil and Mexico, several multinational companies are focusing on building manufacturing facilities due to advantages such as cost reduction and easy access to the global market. The number of API manufacturers is also increasing, which motivates the calcium pantothenate API market in the region.
Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=23948
Key players operating in the global calcium pantothenate API market include Yifan Xinfu, Shandong Xinfa, DSM, BASF, and Shandong Huachen. Out of these, BASF and DSM are leading companies and account for significant shares in the global calcium pantothenate API market.
About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.